论文部分内容阅读
目的:探讨替米沙坦联合阿魏酸钠治疗糖尿病肾病的方法及疗效。方法:将2009年1月—2011年1月我院收治的糖尿病肾病患者76例随机分为观察组38例(替米沙坦联合阿魏酸钠治疗)和对照组38例(替米沙坦治疗),对两组治疗情况进行比较。结果:两组患者治疗前后的UAER相比差异均具有显著性(P<0.05)。治疗后观察组Scr显著下降(P<0.05),而对照组则无明显变化,治疗后FBG、BUN均无明显变化。结论:替米沙坦联合阿魏酸钠治疗糖尿病肾病疗效明显,值得临床推广应用。
Objective: To investigate the method and effect of telmisartan combined with sodium ferulate in the treatment of diabetic nephropathy. Methods: From January 2009 to January 2011, 76 patients with diabetic nephropathy admitted to our hospital were randomly divided into observation group (38 cases) (telmisartan combined with sodium ferulate) and control group (telmisartan Treatment), the treatment of two groups were compared. Results: There was significant difference in UAER between the two groups before and after treatment (P <0.05). After treatment, the Scr in observation group decreased significantly (P <0.05), but there was no significant change in control group. There was no significant change in FBG and BUN after treatment. Conclusion: Telmisartan combined with sodium ferulate for the treatment of diabetic nephropathy obvious effect, it is worthy of clinical application.